June 10, 2025 /

Webinar: Dyne Therapeutics — The Clinical Impact of the FORCE™ Platform for Duchenne

Parent Project Muscular Dystrophy by: Parent Project Muscular Dystrophy

Dyne Therapeutics joined PPMD on Wednesday, June 4, 2025 for a community webinar on the DELIVER clinical trial evaluating DYNE-251. The Dyne team provided the latest updates on the Phase 1/2 global DELIVER study of the company’s investigational therapy for individuals living with Duchenne who are amenable to exon 51 skipping.

Research & Clinical Trial Webinars,
Webinars

Join Our Mailing List

BBB Accredited Charity logoCharity Navigator Four Star Charity logoNational Health Council Standards of Excellence Certification Program logo